Researchers have developed a new type of oral painkiller for chronic abdominal pain, inspired by the peptide hormone oxytocin, which is known for triggering contractions during childbirth. Researchers ...
One of the most buzz-worthy skincare ingredients at the moment is all about plumping and replenishing the skin: peptides.
The following is a summary of “Improvement of irritable bowel syndrome with glucagon like peptide-1 receptor agonists: a systematic review and meta-analysis,” published in the March 2025 issue of ...
Research reveals howneurogenic connection can directly trigger inflammatory processes, creating pain patterns that challenge ...
GlobalData on MSN22d
Tris Pharma eyes approval after pain drug triumphs in second Phase III trialThe company previously announced data from another Phase III trial of cebranopadol, which also met its primary endpoint.
Tris Pharma has reported positive topline outcomes from its ALLEVIATE-1 Phase III trial of cebranopadol for treating moderate-to-severe acute pain in individuals post-abdominoplasty surgery.
These results add to the growing body of data underscoring the promising efficacy and safety profile of cebranopadol, a first-in-class pain therapy involving dual-nociceptin/orphanin FQ peptide ...
Atogepant vs placebo for the preventative treatment of migraine alleviated migraine symptoms across 3 clinical trials on day 1.
Nanogels with specialized peptides enhance antibiotic delivery, effectively treating recurrent urinary tract infections at ...
Hosted on MSN2mon
Breakthrough therapy repairs cartilage damage in under 4 hoursIn severe cases, cartilage wears so thin that joints essentially become bone-on-bone, causing significant pain and loss of function. The primary treatment ... a circular peptide to mimic the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results